Skip to content

Clinical trials

Observational Leukemia, Myelogenous, Chronic, BCR-ABL Positive trials with unknown status

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Leukemia, Myelogenous, Chronic, BCR-ABL Positive Phase: Observational Status: Unknown status Clear all

28 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20071
20091
20102
20112
20132
20144
20151
20161
20172
20183
20192
20213
20221
20231
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Unknown status28

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Gruppo Italiano Malattie EMatologiche dell'Adulto4
Seoul St. Mary's Hospital4
Assiut University2
Nanfang Hospital, Southern Medical University2
Alliance for Clinical Trials in Oncology1
Ankara University1
Center for International Blood and Marrow Transplant Research1
HaEmek Medical Center, Israel1
Imperial College Healthcare NHS Trust1
Institut Bergonié1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Leukemia, Myelogenous, Chronic, BCR-ABL Positive28
Leukemia, Myeloid, Acute3
Leukemia, Myeloid, Chronic-Phase3
Precursor Cell Lymphoblastic Leukemia-Lymphoma3
Anemia, Refractory, with Excess of Blasts2
Breast Neoplasms2
Colonic Neoplasms2
Leukemia2
Leukemia, Lymphocytic, Chronic, B-Cell2
Breast Neoplasms, Male1

Trials

Showing 1 to 25 of 28. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.